recent publications

• academic article

  • Mahaffey, K. W., Roe, M. T., Kilaru, R., Alexander, J. H., Van de Werf, F., Califf, R. M., Simoons, M. L., Topol, E. J., Harrington, R. A. Creatine kinase-mb elevation after coronary artery bypass grafting surgery in patients with non-st-segment elevation acute coronary syndromes predict worse outcomes: Results from four large clinical trials European Heart Journal  2007 28:425-432  DOI:10.1093/eurheartj/ehl483  PMID:17267458
  • Galla, J. M., Mahaffey, K. W., Sapp, S. K., Alexander, J. H., Roe, M. T., Ohman, E. M., Granger, C. B., Armstrong, P. W., Harrington, R. A., White, H. D., Simoons, M. L., Newby, L. K., et al. Elevated creatine kinase-mb with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: Results from 4 large clinical trials American Heart Journal  2006 151:16-24  DOI:10.1016/j.ahj.2005.01.045  PMID:16368286
  • Mahaffey, K. W., Roe, M. T., Kilaru, R., French, J. K., Alexander, J. H., Berdan, L. G., Van De Werf, F., Simoons, M. L., Weaver, W. D., White, H. D., Lincoff, A. M., Kleiman, N. S., et al. Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes American Journal of Cardiology  2005 95:1404-1408  DOI:10.1016/j.amjcard.2005.02.005  PMID:15950560
  • Rebeiz, A. G., Johanson, P., Green, C. L., Crater, S. W., Roe, M. T., Langer, A., Giugliano, R. P., Lincoff, A. M., Newby, L. K., Harrington, R. A., Topol, E. J., Califf, R. M., et al. Comparison of st-segment resolution with combined fibrinolytic and glycoprotein iib/iiia inhibitor therapy versus fibrinolytic alone (data from four clinical trials) American Journal of Cardiology  2005 95:611-614  DOI:10.1016/j.amjcard.2004.10.038  PMID:15721101
  • Roe, M. T., Mahaffey, K. W., Kilaru, R., Alexander, J. H., Akkerhuis, K. M., Simoons, M. L., Harrington, R. A., Tardiff, B. E., Granger, C. B., Ohman, E. M., Moliterno, D. J., Lincoff, A. M., et al. Creatine kinase-mb elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes European Heart Journal  2004 25:313-321  DOI:10.1016/j.ehj.2003.12.009  PMID:14984920
  • Mahaffey, K. W., Roe, M. T., Dyke, C. K., Newby, L. K., Kleiman, N. S., Connolly, P., Berdan, L. G., Sparapani, R., Lee, K. L., Armstrong, P. W., Topol, E. J., Califf, R. M., et al. Misreporting of myocardial infarction end points: Results of adjudication by a central clinical events committee in the paragon-b trial American Heart Journal  2002 143:242-248  DOI:10.1067/mhj.2002.120145  PMID:11835026
  • Mukherjee, D., Mahaffey, K. W., Moliterno, D. J., Harrington, R. A., Yadav, J. S., Pieper, K. S., Gallup, D., Dyke, C., Roe, M. T., Berdan, L., Lauer, M. S., Manttari, M., et al. Promise of combined low-molecular-weight heparin and platelet glycoprotein iib/iiia inhibition: Results from platelet iib/iiia antagonist for the reduction of acute coronary syndrome events in a global organization network b (paragon b) American Heart Journal  2002 144:995-1002  DOI:10.1067/mhj.2002.126118  PMID:12486423
  • Roe, M. T., Granger, C. B., Puma, J. A., Hellkamp, A. S., Hochman, J. S., Ohman, E. M., White, H. D., Van de Werf, F., Armstrong, P. W., Ellis, S. G., Califf, R. M., Topol, E. J. Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention American Journal of Cardiology  2001 88:1403-6, A6  DOI:10.1016/s0002-9149(01)02119-1  PMID:11741559
  • Aronow, H. D., Topol, E. J., Roe, M. T., Houghtaling, P. L., Wolski, K. E., Lincoff, A. M., Harrington, R. A., Califf, R. M., Ohman, E. M., Kleiman, N. S., Keltai, M., Wilcox, R. G., et al. Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: An observational study Lancet  2001 357:1063-1068  DOI:10.1016/s0140-6736(00)04257-4  PMID:11297956
  • Peterson, J. G., Topol, E. J., Roe, M. T., Sapp, S. K., Lincoff, A. M., Deckers, J. W., Blackstone, E. H., Harrington, R. A., Califf, R. M., Lauer, M. S., Investigators, Pursuit Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes American Journal of Cardiology  2001 87:532-536  DOI:10.1016/s0002-9149(00)01426-0  PMID:11230834
  • Roe, M. T., Harrington, R. A., Prosper, D. M., Pieper, K. S., Bhatt, D. L., Lincoff, A. M., Simoons, M. L., Akkerhuis, M., Ohman, E. M., Kitt, M. M., Vahanian, A., Ruzyllo, W., et al. Clinical and therapeutic profile of patients presenting with acute coronary syndromes who do not have significant coronary artery disease Circulation  2000 102:1101-1106  PMID:10973837
  • Marso, S. P., Bhatt, D. L., Roe, M. T., Houghtaling, P. L., Labinaz, M., Kleiman, N. S., Dyke, C., Simmoons, M. L., Califf, R. M., Harrington, R. A., Topol, E. J., Investigators, Pursuit Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting Circulation  2000 102:2952-2958  PMID:11113045